., '" for other substituted aromatic acids. With p-ethylphenylalanine, the reaction was slower than with tyrosine and it was necessary to use a much greater (by an order of magnitude) excess of chymotrypsin. Optical purity of the obtained amino acid was checked by HPLC on a dynamically anchored dural phase"? (copper complex of t-phenylalanine}, The reagent of choice for the preparation of optically pure p-ethylphenylalanine proved to be penicillin amidohydrolase (E.C.3.S.1.11.), particularly its immobilized form 1 B , 1 9. Contrary to the previous opinions 2 0 -2 2 , this enzyme cleaves partially (and apparently according to the reaction conditions) also phenylacetyl-n-amino acids". In the case of phenylacetyl-p-ethyl-nt-phenylalanine the acyl moiety is removed from the D-amino acid substantiaIIy more slowly. If the reaction is stopped at the moment of almost complete conversion of the L-form derivative, the optically pure amino acid is obtained. The reaction course was followed by liquid chromatography on a reversed phase, the arising phenylacetic acid as well as the disappearing acylated component being detected by absorption at 244 nm. The optical purity of the derived amino acid was checked by chromatography! 7 and by incubation with t-amino acid oxidase.
The obtained amino acids Were converted into their o-nitrobenzenesulfenyl derivatives (except p-chlorophenylalanine which was used as the Boc derivative 2 4 ) which were characterized as such or as dicyc1ohexylammonium salts. For the acylation of the heptapeptide lID we prepared in all cases the corresponding 2,4,S-trichIorophenyl esters. In cases when the active ester did not crystallize we performed the acylation with the oily prodnct. Data for the amino acid derivatives are listed in Table II. lt was tempting to use chymotrypsin in acylation of the heptapeptide IIa because it wonld be possible to work with the racemic aromatic amino acid. In the case of p-ethylphenylalanine the rate of the concurrent removal of the terminal glycinamide was comparable with that of the desired reaction (as found by an HPLC kinetic study] and therefore this approach conld not be realized. The properties of the prepared octapeptides lIb -IIi are given in Table III. The octapeptides were cyc1ized after transformation of the free carboxyl into the active ester in pyridine using the high dilution technique. In accord with the literature data" better yields were obtained with 2,4,5-trichlorophenyl than p-nitrophenyl ester; we found also that it was not necessary to add N-ethylpiperidine to the cyc1iza-tion solution. Good resnlts Were obtained also with cyclization of hydroxybenzotriazolyl ester in methanolic solntion; the active ester was prepared, after removal of the amino-protecting group, from the octapeptide hydrochloride-•.
The cyc1ization products Were purified by filtration throngh an ion exchange resin, gel filtration, free-flow electrophoresis and countercurrent distribution. Neither of these methods afforded a pure, sulfoxide-free prodnct". Liqnid chromatography on a reversed phase with methanol as the mobile phase proved to be the most effective method. The compound 1111 was purified in a phosphate buffer (the product was desalted on a small column with a reversed phase") or better in a triethylammonium hydrogen carbonate buffer which was removed by freeze-drying. Use of 0·1% trifluoroacetic acid '? did not lead to a pure product. The corresponding sulfoxides arising as side-products in all the cyclizations, were separated by liquid chromatography as peaks of lower k' values. The oxidation state of sulfur in the prepared compounds was checked by liquid chromatography-?
(k' values of the analogues and their sulfoxides are given in Table IV ). We did not observe any chromatographic separation of the diastereoisomeric sulfoxides (if both forms arise at all) which is not surprising for the 6-carba-analogues,o,31. Compound Ig was the most interesting of the prepared analogues and we prepared for biological testing also its sulfoxide Iii by oxidation with sodium periodate. The product was desalted and purified by liquid chromatography on a reversed phase. On the other hand, we confirmed again that the analogue Ig, contaminated with its sulfoxide (e.g. as the result of precipitation from methanol by peroxide-containing ether) can be reduced with hydrogen bromide and acetone'2.". After storing Ig in aqueous methanol for half a year at room temperature, no sulfoxide or degradation products were detected (HPLC).
The compound II was prepared by removal of the benzyloxycarbonyl protecting group from compound 1/1 or by reduction of the nitro group in compound 10 with sodium in liquid ammonia. Both methods gave the same compound. The properties of the prepared analogues are given in Table IV . Synthesis of the compound Ii was described earlier!".
Biological activities of the synthesized analogues and some reference compounds are given in Table 1 .From the structural point of view, the analogues differ only in the para-substituent in the aromatic amino acid in the position 2 (substituted nitrogen atom, alkylether or alkyl groups, hydrogen or chlorine atoms). A strong drop in all activities, including the natriuretic one, was observed with the analogues containing the para-nitrogen atom (compounds 1/ to 10). The however, also other activities are relatively high although they are lower than those of the parent deamino-ti-carba-oxytocin (Iel). The highest degree of dissociation between the natriuretic and other activities (with a high natriuretic activity) was found for the para-ethyl derivative Ig. * Its sulfoxide Iii has only about half of activity of the compound Ig; this is in agreement with the previous observations with 6-carba analogues". Pressor activity of all the prepared analogues was very low or negligible and also the galactogogic activity (except compounds Ie and I k) did not reach even one tenth of the o_xytocin activity. Although the studied analogues increased also
This analogue is now under study as a potential salureticum under the generic name Nacartocln.
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renal excretion of potassium, the increase was relatively small compared with the natriuretic effect. The half-time estimated on the basis of antidiuresis in Burn's test was in all cases lower than for the starting compound I d. This means that these differences in the half-time are not caused by enzymatic cleavage but by the rate at which the compounds are removed from the receptor compartment. Also the index of persistence'" for the uterotonic effect, related to the elimination constant of oxytocin (k = 0·237) was for all the analogues lower than for the compound Id.
CH., R 2 CH.,
10, R 1 = H,
All the analogues (except compound Ill) had higher ill vivo than ill nitro uterotonic activities. In some cases the difference was only small but for compounds Ij, lm and 10 it amounted several orders of magnitude. If we consider that the ill vivo test involves many processes in which the tested compound may undergo degradation or transformation into other types of compounds (such as oxidation to sulfoxide, .. Although we have proved that compounds with suhstantially higher, and to significant extent selective, natriuretic effect can be prepared on the basis of oxytocin structure, the question of mechanism of this effect still remains open. It seems probable that this mechanism is identical with that of the oxytocin action, judging not only from the similar Course of action of oxytocin and the prepared analogues hut also from the fact that the natriuretic effect of the compound Ig can be blocked by a specific oxytocin inhibitor?". equipped with an SP~8400 detector and an SP-4100 integrator (all from Spectra-Physics, Santa Clara, USA). Immobilized Escherichia coli cells of retained penicillin amidohydrclase activit y1 8 were used. L-Amino acid oxidase (0'3 U/rng) was a Serva product.
S~(J3-Carboxyethyl)homocysteine
The title compound was prepared according to ref. 1 3 by reftuxing methionine (5 g) and J3-bromop ropionic acid (5'4 g) in concentrated hydrochloric acid (67 rnl} for 25 h. The solution was taken down and the residue coevaporated twice with water. An aqueous solution of the residue was applied to a column of Dowex-50 (H+ -cycle; 100 ml). The column was washed with water and the product eluted with 3% ammonium hydroxide solution. The eluates were taken down and the residue crystallized from a mixture of acetic acid (80 ml) and water (30 ml Dicyclohexylammonium salt of Tert-butyloxycarbonylwS~<a-methoxycarbonylethyl)homo cysteine 2w(Tert-butyloxycarbonyloxyimino)-2~phenylacetonitrile (3 g) was added to a solution of 8-(Bwmet hoxycarbonylethyljhcmooystelne (1'8 g) and triethylamine (1'7 ml) in aqueous acetone (1 : 1; 30 ml). The acylation was followed by thin-layer chromatography. After disappearance of the starting compound (I8 h) the acetone was evaporated, the solution acidified with citric acid and the product taken up in ethyl acetate. The extract was washed with water, dried over sodium sulfate and taken down, yielding an oil which was dissolved in ethyl acetate. Dicyclohexylamine (loS ml) Collection Czechoslovak Chern. commun. Ivot. 47J [1982J was added and after cooling the separated crystals were collected on filter and washed with light petroleum, affording. 2·69 g (54%) of product, m.p. 98-101°C, The analytical sample was crystallized from ethyl acetate; m.p. 99-101°C; [0:]0 +10-6°(c. 0·2 dimethylformamide). For C2sH46N206S (502'7) calculated: 59-73% C, 9-22% H, 5'67% N; found: 59'84% C, 9-29% H, 5-40% N_ N,S·Bis-Ca-methoxycarbonylethyl)homocysteine Homocystine (l g) was reduced with sodium in liquid ammonia (about 100 mI) until the blue coloration persisted for 8 min. The solution was decolorized with ammonium chloride, methyl acrylate (2 mil was added and the mixture was freeze-dried. The product was de-salted by washing with water on a column of Dowex 50 (H+ form; 40 ml) and eluted with 10% pyridine. Evaporation and precipitation from methanol and ether afforded l-B g of compound m.p. 213 to 217°C, which on crystallization from water melted at 217-219°C. 
Ethylo-Ethyl-DL-phenylalaninate Hydrochloride
A slurry of p-ethylphenylalanine (5'0 g) in absolute ethanol (300 ml) was saturated with hydrogen chloride at DoC. After standing for 12 h at room temperature, the solution was several times evaporated with ethanol, affording 6'25 g (94%) of the ethyl ester, m.p. 160-163°C. R F 0'52 (Sl ), 0-66 (S2), 0-53 (S3), 0-68 (S4)_ For C 13H2 0CIN02 (257-8)calculated: 60-57% C, 7-82% H, 5-43%N; found: 60'36% C, 7'66% H, 5·22% H. Cleavage with chymotrypsin: The ethyl ester (6'2 g) was dissolved in water (200 ml), and the solution adjusted to and kept at pH 5'0 with 0'2M lithium hydroxide. After addition of chymotrypsin (220 mg) the formation of p-ethylphenylalanine was followed by liquid chromatography (Separon SI-C~18, methanol-phosphate buffer, pH 4 (4: 1), ethyl ester k' = 3'9, free acid k' = 1'05). The cleavage was very slow and therefore the mixture was adjusted to pH 6'3. After 14 h only 13% of the substrate reacted. The chymotrypsin activity was checked in this stage by addition of methyl tyrosinate to a sample (lOOl.d) of the reaction mixture; this sample was cleaved very rapidly. Further 1'4 g of the enzyme was added to the incubation mixture and the reaction was prolonged for 10 h at 37°C. The mixture was filteredc.the filtrate concentrated to a small volume and after standing in a refrigerator for two days the separated crystals were filtered, washed with water and dried, yielding 1'5 g (65%) of compound, identical (according to thin-layer chromatography and electrophoresis) with authentic p-ethylphenylalanine. The optical purity of the product was found to be 88% by reversed phase liquid chromatography on Separon SI-C-18, using a chiral mobile phase (0'008M phenylalanine, 0'004M CuS04 -I-45% methanol) in which the k' values for the D and L forms were 6,63 and 7·62, respectively. N-Phenylacetyl-p..-ethyl-oL-phenylalanine Phenylaceryl chloride (3 m1) was added portionwise at 10°C during 30 min to a suspension of p-ethylphenylalanine (2 g) in 2M-NaOH (7 ml}, Simultaneously, 2M-NaOH was added so as to keep the mixture at pH 12. The suspension was then stirred for 2 h at room temperature, acidified with concentrated hydrochloric acid to pH 2 and set aside overnight in a refrigerator. The product was filtered, washed with water, dried and crystallized from 30% ethanol, affording 2,65 g (92%) of compound. m.p. l46-l49'C. R F 0'93 (51), 0'50 (52),0'86 (53),0'61 (54). For ClgH21NOJ (311,4) calculated: 73'29% C, 6'80/~H, 4'50% N; found: 72'98% C, 6'68% H, 4'32% N.
Cleavage of Phenylacetyl~p~ethyl-DL-phenylalanine with Penicillin Amidohydrolase (E.C.3.5.1.11)
A suspension of phel1ylacetyl-p~ethyl~DL-phenylalanine (1'1 g) in water (40 ml) was adjusted to pH 7'S with O'IM-NaOH (3'1 ml). To the formed solution 0'2M phosphate buffer, pH 7·S (13 ml) and the immobilized enzyme 18 (l g) were added and the mixture was stirred at 40"'C.
Course of the cleavage was followed by HPLC (Separon SI-C~IS,~ethanol-O'OS% trifluoroacetic acid SO: 20; k' values: phenylacetic acid 1'19, phenylacetyl-p-ethylphenylalanine 2,11, p-ethylphenylalanine 2'84), After 3 h the mixture was filtered, the filtrate acidified with IN/-Hel (10 ml), filtered and applied to a column of Dowex SOW (60 ml). After washing with water the product was eluted with IS% pyridine. Evaporation of the solvent afforded 234 mg (68'5%) of p-ethylphenylalanine identical (TLC, electrophoresis) with authentic compound. The optical purity, determined by HPLC using a chiral mobile phase (vide supra) was >99; this value was confirmed also by incubation of the sample with L-amino acid oxidase. The product was crystallized from IM-HCl, rn. 
Preparation of e-Nitrobenzenesulfenylarnino Acids
The amino acid {I-B mmoI) was dissolved in a mixture of Ixr-Na Obl (1'8 ml) and peroxide-free dioxane (2'S ml). o-Nitrobenzenesulfenyl chloride (0·6 g) and 2M-NaOH were added at such a rate to keep the mixture at pH 8·5 (glass electrode), The reaction mixture was poured into water (O°C,20 ml), filtered, and the filtrate acidified with 0'SM-H 2S04 to pH 3. The product was taken up in ethyl acetate, the organic solution washed with water, dried and taken down. If the residue did not crystallize even after trituration with light petroleum, it was dissolved in ethyl acetate, an equivalent quantity of dicyclohexylamine was added and after cooling the separated crystals were filtered, washed with ether and dried. The characteristics of the prepared derivatives are given in Table II .
Preparation of 2,4,5-Trichlcrophenyl Esters of Protected Amino Acids
The protected amino acid (l mmol) was liberated from its dicyclohexylammonium salt by addition of 0'05M sulfuric acid, extraction into ethyl acetate and evaporation of the solvent. After dissolution in dichloromethane (10 ml) or its mixture with dimethylformamide (l : 0, addition of 2,4,5-trichlorophenol (200 mg) and cooling to -20 oe, dicyclohexylcarbodiirnlde (230 mg) was added. The solution was stirred at -20 oe for Ih,atOOe for another hour and at room temperature for 10 h. The mixture was filtered. taken down, washed with light petroleum and; if desirable, the product crystallized from ethanol. For data of the prepared active esters see Table II .
2,4,S-TrichlorophenoI (0'29 g) and dicyclohexylcarbodiimide (0'33 g) were added to a solution of o-nitrobenzenesulfenyI-p-nitrophenylalanine (0'53 g) in a mixture of dichloromethane (15 ml) and dlmethylformamide (15 ml), cooled to _lO°e. After stirring at -lO"C for 1 h, the mixture was stirred at room temperature for 12 h, and concentrated ill vacuo. The separated dicyclohexylurea was filtered off, the cake on the filter washed with dichloromethane and the filtrate taken down. The residue was triturated several times with light petroleum and dissolved in dimethylformamide (12 ml). Compound fIa (0'8 g) was suspended in this solution and the mixture was stirred at room temperature for 135 h. The formed solution was taken down, the product which crystallized on trituration with light petroleum and ether was washed on the filter successively with water, O'OSM sulfuric acid, water and ether, affording 720 mg (63%) of compound whose characteristics are given in Table III .
Bis(p-nitrophenyl) sulfite (0'7 g) was added to a solution of the octapeptide lIb (200 mg}in a mixture of dimethylformamide (7 ml) and pyridine (7 ml) under nitrogen. After stirring at room temperature for 9 h, another portion of the sulfite (0'7 g) was added and after standing for 12 h, the addition was completed by the last portion of sulfite (0'35 g). After standing for 4 h the mixture was concentrated and the product precipitated with ether, filtered and washed with ether. After drying, the product was dissolved in dimethylformamide (7 ml), the solution mixed with 2·26M hydrogen chloride in ether (0'52 ml) and after 7 min diluted with ether (loa ml). The separated precipitate was filtered, washed with ether, dried in vacuo and dissolved in dimethylformamide (7 ml). This solution was added at a rate 2 rnljh into a vigorously stirred mixture of pyridine (200 ml) and Neethylpiperidine (50 ul), warmed to 50°C, into which nitrogen was bubbled. After the end of the addition the mixture was kept at 50°C for 4 h and then set aside for 12 h at room temperature. The solution was concentrated to a small volume and the product precipitated by addition of ether; yield 170 mg. A part of the product (100 mg) was dissolved in 3M acetic acid (4 ml) and applied on a column of Bie-Gel p-z (100 X 1 ern). Freeze-drying of the corresponding fractions afforded 70 mg of compound which was again dissolved in 3M acetic acid (3 ml) and applied on a column of Bie-Gel P-4 (100 X 1 ern). Freeze-drying of the appropriate fractions gave 42 mg of the compound. A portion (15 mg) was dissolved in a mixture of methanol and water (2: 3; 2 ml) and the solution applied on a column of Separon SI-C-18 (15 X 0·6 ern). The elution was carried out with a methanol-water (44: 56) mixture (at 20 MPa).
The fraction of k' = 8·2 was concentrated in vacuo and freeze-dried, affording 6·2 mg of product.
11s physical constants are given in Table IV. o-Nitrobenzenesulfenylphenylalanyl-isoleucylwglutaminyl-asparaginyI--Sw(J}-carboxyethyl)homocysteinYl-prolyl-leucyl-glycine Amide (Ile) 2,4,5-TrichlorophenyI o-nitrobenzenesulfenylphenylalaninate (0'8 g) was added to a suspension of the free heptapeptide IIa (0'8 g) in dimethylformamide (15 ml}, After stirring at room temperature for 96 h the jnixture was worked up as described for the preparation of the compound IIb affording 1 g (85%) of compound whose characteristics are given in Table III .
The cyc1ization was carried out in the same way as described for the compound 10. Since the product contained some ninhydrin-positive compound, it was dissolved in aqueous methanol (l : 1) and filtered through a column of Dowex 50 (H+ form, 5 ml). Concentration and freeze--drying afforded 125 mg of compound which was further purified by gel filtration on Bie-Gel P-4 (100 X 1 em) in 3M acetic acid. Part of the thus-obtained material (15 mg) was chromategraphed on a column of Scparon SI-C-18 (15 X 0·6 em) in a mixture of methanol and water (3 : 2). Fraction of k' = 7·0 on concentration and freeze-drying afforded 4'2 mg of the product described in Table IV. 0-Nitro benzenesulfeny l-p-me thy lp henylalany1R isoleucyl-gl utaminyl-asparaginy1--S-(pRcarboxyethyl)homocysteinYI-prolyl-leucyl-glycine Amide (IId)
The active ester (0'65 g) was added to a suspension of the heptapeptide Ila (0'65 g) in dimethylformamide (13 ml). The same procedure as described for the preparation of the compound lIb afforded 0'83 g (96%) of product; described in Table III. [2-p-Methylphenylalanine]deamino-6-carba-oxytocin (If) Cyclization of the peptide IJd (200 mg) was carried out in the same manner as described for 10. affording a product (l80 mg) a part of which (50 mg) was purified by gel filtration on a column of Bie-Gel P R4 in 3M acetic acid and by repeated chromatography on a column (25 X 0·4 em) of Separon SI-C-18 in methanol-water (3: 2). Lyophilization of fractions of k' = 5·03 gave 13'6 mg of compound. described in Table IV .
The heptapeptide Ila (4'4 g) was suspended in a dimethylformamide solution (l00 ml) of the active ester. prepared from dicyclohexylammonium salt of o-nitrobenzenesulfenyl-p-ethylphenylalanine (3'3 g) analogously as described for lIb. The suspension was adjusted to pH 8 with Ncethylpiperidine (0,5 ml) and stirred for 24 h at room temperature. Further addition ofthe base (O'B'ml) was necessary. After 120 h the mixture was worked up as described for Ilb, affording 5·1 g (83%) of compound described in Table Ill. [2-p-Ethylphenylalanine]deamino-6-earba-oxytocin (Ig) a) Bis(2,4,S-trichlorophenyl) sulfite (5 g) was added to a solution of the octapeptide lIe (l g) in a mixture of pyridine (40 ml) and dimethylformamide (40 ml) into which helium was introduced. After 3 h another portion of the sulfite (5 g) was added. After 12 h the mixture was concentrated in vacuo, the product precipitated. washed with ;ther, dried and dissolved in dimethylformamide (40 ml ). An ethereaI3'45M-HCI solution (1,5 ml) was added and after standing for 10 min at room temperature ether was added to precipitate the hydrochloride of the octapeptide active ester. The compound was washed with ether, dried in 11QCllO, dissolved in dimethylformamide (30 ml) and the solution added under helium at the rate 5 mljh into stirred pyridine (900 ml) warmed to 50°C. The mixture was concentrated and the product (0'71 g) precipitated with ether. A part of the product (200 mg) was purified by gel filtration on a Sephadex LH-20 column (100 X X 2·5 cm) in dimethylformamide and on a Bio-Gel P-4 column (100 X 1 em) in 3M acetic acid. However, the obtained product was still not completely homogeneous (thin-layer and HPLC). Another part (300 mg) was dissolved in the upper phase (50 ml) of the system sec-butyl a1cohol-O·05% aqueous acetic acid and subjected to countercurrent distribution (564 transfers of the lower phase and 198 transfers of the upper phase). The peptidic material was detected by liquid chromatography on a reversed phase, which determined directly also the purity of the desired compound in the given tube. Freeze-drying of the compound of K = 4'32 (tubes afforded 94 mg of the product which, according to HPLC was contaminated with the sulfoxide (21%). The sulfoxide was the principal part of the material of K = 3'64 (tubes 25-43; 32 mg) .
A further part of the crude product (100 mg) was dissolved in methanol (5 fill) and mixed with water (5 ml). The precipitate (which, according to HPLC analysis, contained only a minimum amount of the desired compound) was filtered and the filtrate (10 ml) applied on a column of Partisll ODS (50 X 0'9 em). The product was eluted with a mixture of methanol and water (3 : 2). Concentration and freeze-drying of the fraction of Ie' = 9 afforded 22 mg of the pure compound; see Table IV . Fraction of k' = 6·9 contained the corresponding sulfoxide (12 mg).
The combined fractions, containing the sulfoxide (60 mg), were suspended in acetone (2 rnl), hydrogen bromide in acetic acid (0'5 ml) was added and after standing for 5 min at DoC the solution was freeze-dried and repeatedly evaporated with acetone. The obtained material was purified by chromatography on Partisil ODS, affording 38 mg of the compound Ig. A part (5 mg) of the product was dissolved in 3M acetic acid (0'4 ml) and applied on a column of Bio-Gel P-2 (12 X 0·8 em). Freeze-drying of the corresponding fractions gave 2·5 mg of product, b) The protected octapeptide (200 mg) was dissolved in dimethylformamide (5 ml), mixed with 3'6MwHCI in ether (0'5 ml) and allowed to stand at room temperature for 7 min. The product was precipitated with ether, dried, and dissolved in dlmethylformamide (3 ml) and dioxane (1'8 ml). j-Hydroxybenzorrlazole (241 mg) was added, the mixture was cooled to DoC and after addition of dicyclohexylcarbodiimlde (265 mg) stirred at DoC for 0'5 h and at room temperature for 2 h. The precipitate was filtered, washed with dimethylformamide and the filtrate divided into two parts. One was dissolved in a mixture of methanol (100 ml) and Neethylpiperidine (300 Ill). The solution was kept at 50 0 e for 2 h. concentrated and the product precipitated with ether, affording 76 mg of the crude product. The second part of the active ester was treated with pyridine (100 ml) at 50°C for 2 h. The mixture was worked up in the same manner affording 56 mg of the crude product. Preparative liquid chromatography (the same conditions as described under a» afforded 13 rng and 8 mg of the pure compound from the respective first and second part. The product had the same properties as the material obtained under a).
[2-p-Ethylphenylalanine]deamino w6-carbaMoxytocin Sulfoxide (III) Sodium periodate (2'5 mg} was added to a solution of Ig (8 mg) in aqueous methanol (1 : 1; 1 ml). After standing for 70 min at room temperature, the solution was applied on a column of Partisil ODS (50 X 0'9 cm) and eluted with a mixture of methanol and water (3 : 2). The fraction of k' = = 6'92 was concentrated and freeze-dried, affording 6'4 mg of product; see Table IV .
The preparation of the active ester and condensation with-the heptapeptide I/a (0'25 g) was carried out in the same manner as described for the preparation of lIb and afforded 200 mg (69%) of product; see Table III .
The cyclization was performed analogously to that described for the compound 10 and yielded 196 mg of the crude cyclization product from 200 mg of the protected peptide. A part (30 mg) of this mixture was purified by repeated gel filtration on a column of Bie-Gel P-4 (100 X 1 em) in 3M acetic acid, giving 8'3 mg of compound. A part (5 mg) of this product was dissolved in aqueous methanol (l : 1; 0'5011) and applied on a column of Scparon SI-C-18 (25 X 0'4 em). The elution was carried out with a mixture of methanol and water (11 : 9) and the fraction of k' = 5·2 was concentrated ill vaello and freeze-dried, affording 3·2 mg of compound, described in Table IV .
Tert-butyloxycarbonyl-p~chlorophenylalanyl-isolel1cyl-glutaminyl-asparaginyl S-(p-carboxyethyl)homocysteinyl-prolyl-leucyl-glycine Amide (lIg) Tert-butyloxycarbonyl-p-chlorophenylalanine 2 4 (0'3 g) was dissolved in dichloromethane (6'5 ml) and the active ester was prepared in the same manner as described for compound lIb. The active ester was dissolved in dimethylformamide (12 ml) and the heptapeptide lIa (0'7 g) was suspended in this solution. After stirring for 80 h at room temperature the solution was worked up analogously as described for lIb. Yield D'7! g (73%) of product (see Table Ill ).
[2-p-Chloro phenylalanine ]dea mino-S-car ba-oxytcci n (lk)
The cyc1ization (starting from 200 mg) and work-up procedure were the same as for 10 except that the prepared active ester was dissolved in trifluoroacetic acid and after reaction at room temperature for 1 h the formed solution was co-evaporated with toluene. No strong base was added into the cyclization solution. The reaction gave 176 mg of product. A part (50 mg) was dissolved in 35% methanol (10 ml) and applied on a column of Partisil ODS (50 X 0'9 cm); elution with a mixture of methanol and water (11 : 9). The fraction of Ie' = 10'2 was concentrated and freeze-dried, affording 17 mg of product; see Table IV .
The corresponding active ester (0,8 g) was added to a suspension of the heptapeptide lIa (0'6 g) in dimethylformamide (15 mI). The further work-up procedure was the same as described for the compound lIb and afforded 0'53 g (55%) of the product described in Table III .
The cyc1ization (from 200mg) was carried out in the same manner as described for the compound Io and afforded 156 mg of the product a part of which (40 mg) was purified by gel filtration on a column of Sephadex LH-20 (2'5 X 100 cm) in dimethylformamide and on a column of Bie-Gel P-4 (l00 x 1 cm) in 3M acetic acid. Another part (30 mg) of the crude product was purified by chromatography on a column (50 x 0'9 cm) with a reversed phase (Partisil ODS-2)
in methanol-water (3 : 2). Freeze-drying of the fraction containing the compound of k' = 12'5 afforded 3·7 mg of compound described in Table IV .
o-Nitrobenzenesulfenyl~p~dimethylaminophenylalanyl-isoleucyl-glutaminyl~asparaginyl -S-(p-carboxyethyI)homocysteinyl-prolyl-leucyI-glycine Amide (IIi) The corresponding active ester was added to a suspension of the heptapeptide lIa (0'3 g) in dlmethylformamide. The same procedure as described for lIb (with omission of washing with dilute sulfuric acid) yielded 0·43 g (96%) of product (see Table III ). The cyclization was performed as described for the compound 10 and afforded 190 mg of the product which was purified by gel filtration on a column of Bie-Gel P-4 in 3M acetic acid. The obtained lyophilizate (100 mg) was dissolved in 20% acetic acid and purified by free-flow electrophoresis, yielding 54 mg of a compound which was not homogeneous (HPLC). A part (10 mg) was dissolved in a mixture of methanol and 0'02Ar!triethylammonium hydrogen carbonate buffer pH 8'1 (2: 3; 250 J.11) and in portions applied on a column of Separon SI-C-18 (25 X 0'4 cm); elution with a mixture of the above-mentioned solvents (1: 1). Concentration of fractions of k' = = 12'4 and their repeated lyophilization from water and 1M acetic acid gave 2·4 mg of the product;
see Table IV. 2558
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[2-p-Aminophenylalanine]deamino-6-carba-oxytocin (ll) a) Sodium was added to a solution of [2-p-nitrophenylalanine]deamino-6-carba-oxytocin (/0) (3,6 mg) in liquid ammonia (5 ml) until the blue coloration persisted for 30 s. The mixture was decolorized with acetic acid, the ammonia evaporated and the residue dissolved in 3M acetic acid and applied on a column of Bie-Gel P-4. Freeze-drying of the corresponding fractions gave 2'1 mg of product; see Table IV. b) A 35% solution of hydrogen bromide in acetic acid (1 ml) was added to a slurry of the compound In (30 mg} in acetone (1 ml) and the solution was set aside for 1 h at room temperature. After repeated evaporation with acetone and precipitation from methanol with ether the product was dissolved in 3M acetic acid (3 ml) and purified by gel filtration of Bie-Gel P-4. Freeze-drying afforded 8'7 mg of compound which was dissolved in a mixture of methanol and 0·1% trifluoroacetic acid (2: 3; 1 ml) and applied on a column ofSeparon SI-C-18 (25 X 0'4 em). The elution was carried out with the above-mentioned solvents (9 : 11). The fraction of k' =6'3 was concentrated and repeatedly freeze-dried from 1M acetic acid and water, affording 1·6 mg of product identical with the compound obtained by the procedure a).
Pharmacological Methods
The in vitro uterotonic assay was carried out on isolated rat uterine stri ps43,44. For the determination of the in vivo activi ty45 oestrogenized rats in ethanol anaesthesia were used. Galactogogic activity was determined on ethanol-anaesthesized rats (4-15 days after delivery)46,47. pressor activity on desplnalized rats 4B. Antidiuretic activi ty49,50 was determined on ethanol--anaesthesized rats.
Natriuretic activity was determined using two different modifications: on male Brattleboro (ND!) rats in pentobarbital narcosis and continuous water diuresis 5 1 , and on conscious Wistar rats 4.52. The concentration of sodium and potassium ions in the urine was determined flame--photornetrically. 
